MRPS6 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.311800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.593800E-01
Normal-vs-Stage2
3.040400E-01
Normal-vs-Stage3
4.203400E-01
Normal-vs-Stage4
6.449800E-01
Stage1-vs-Stage2
8.261400E-01
Stage1-vs-Stage3
9.327800E-01
Stage1-vs-Stage4
7.287400E-01
Stage2-vs-Stage3
9.475800E-01
Stage2-vs-Stage4
5.262400E-01
Stage3-vs-Stage4
6.862200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.548200E-01
Normal-vs-AfricanAmerican
4.294200E-01
Normal-vs-Asian
1.989600E-01
Caucasian-vs-AfricanAmerican
6.994200E-01
Caucasian-vs-Asian
5.965200E-01
AfricanAmerican-vs-Asian
9.986200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.163600E-01
Normal-vs-Female
3.552000E-01
Male-vs-Female
7.047200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.870400E-01
Normal-vs-Age(41-60Yrs)
2.640600E-01
Normal-vs-Age(61-80Yrs)
3.903600E-01
Normal-vs-Age(81-100Yrs)
8.692500E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.907420E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.715600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.541700E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.401700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.090000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.293200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.719600E-01
Normal-vs-Daily Drinker
4.928400E-01
Normal-vs-Weekly Drinker
3.230400E-01
Normal-vs-Occasional Drinker
2.449800E-01
Normal-vs-Social Drinker
4.745400E-01
Non Drinker-vs-Daily Drinker
5.156600E-01
Non Drinker-vs-Weekly Drinker
4.542400E-01
Non Drinker-vs-Occasional Drinker
7.811800E-01
Non Drinker-vs-Social Drinker
8.693200E-01
Daily Drinker-vs-Weekly Drinker
9.305600E-01
Daily Drinker-vs-Occasional Drinker
4.225800E-01
Daily Drinker-vs-Social Drinker
5.568400E-01
Weekly Drinker-vs-Occasional Drinker
3.460600E-01
Weekly Drinker-vs-Social Drinker
5.311000E-01
Occasional Drinker-vs-Social Drinker
9.905200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.454000E-01
Normal-vs-Grade 2
9.573900E-02
Normal-vs-Grade 3
1.551250E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.574100E-02
Grade 1-vs-Grade 3
2.502000E-02
Grade 1-vs-Grade 4
3.454000E-01
Grade 2-vs-Grade 3
2.669600E-01
Grade 2-vs-Grade 4
9.573900E-02
Grade 3-vs-Grade 4
1.551250E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.893000E-01
Normal-vs-NonDiabetic
3.531800E-01
Diabetic-vs-NonDiabetic
5.690800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.872440E-01
Normal-vs-NoPancreatitis
3.588400E-01
Pancreatitis-vs-NoPancreatitis
8.496500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.129600E-01
Normal-vs-N1
3.215200E-01
N0-vs-N1
2.769400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.418000E-01
Normal-vs-TP53-NonMutant
9.318200E-01
TP53-Mutant-vs-TP53-NonMutant
2.369700E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
